ABOUT US OUR PRODUCTS & PIPELINE BUSINESS DEVELOPMENT OUR INVESTORS PRESS ROOM CONTACT US
 

ANNOUNCEMENTS

PRESS MATERIALS

PRESENTATIONS

RESEARCH ARTICLES

  

Announcements

Date Anouncement
15 Jul 2011 Publication of Phase IIa asthma trial data for OC000459 shows its promise as a novel oral treatment for asthma and related disorders.
11 Jun 2010 Oxagen Limited announces second closing of its Series C Private Venture Capital Financing
09 Dec 2009 Oxagen Announces Completion of Recruitment in Phase IIb Dose Range-Finding Clinical Trial in New Oral Treatment for Asthma
24 Nov 2009 Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
18 May 2005 Oxagen Ltd Raises $59.8 Million
07 May 2004 Addition to the Board of Directors
Oxagen Limited, 91 Milton Park, Abingdon, Oxfordshire OX14 4RY   t : +44(0) 1235 443300  f: +44(0) 1235 443301  e: oxagen@oxagen.co.uk